SELEPARINA

Medicinal product

(Invented) name

SELEPARINA

Active substance (s)

Nadroparino kalcio druska

Strength

2850 anti-Xa TV/0,3 ml

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

leisti į veną, leisti į arteriją, leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

B01AB06, Nadroparin

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2024-04-19

Date of renewal

Documents

2144_SELEPARINA 2850 PZ_2024-04-19.docx

2144_SELEPARINA 2850 PL_2024-04-19.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

0,3 ml tirpalo yra:	0.3 ml
Nadroparino kalcio druska	2850 anti-Xa TV

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
113506	99625	1099625	užpildytas švirkštas	0,3 ml, N6		Receptinis	LT/L/24/2144/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2024-04-19	Registruotas